Month: September 2020

MALVERN, Pa., Sept. 18, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced Gerri Henwood, the Company’s President and Chief Executive Officer, will present at the Oppenheimer Fall Healthcare Life Sciences & Medtech Summit on Tuesday, September 22, 2020 at 3:20 p.m. ET.A live webcast of the presentation will be available on the “Presentations” page within the Investors section of the Baudax Bio website at https://www.baudaxbio.com/news-and-investors. A replay will be available on the Baudax Bio website for a period of 30 days following the event.About Baudax BioBaudax Bio is a pharmaceutical company focused on therapeutics for acute care settings. The launch of the Company’s first commercial product, ANJESO®, began in June of 2020....

Series  RIKB 23 0515Settlement Date  09/23/2020Total Amount Allocated (MM)  7,500All Bids Awarded At (Price / Yield)  99.510 / 1.690Total Number of Bids Received  22Total Amount of All Bids Received (MM)  16,650Total Number of Successful Bids  13Number of Bids Allocated in Full  11Lowest Price / Highest Yield Allocated  99.510 / 1.690Highest Price / Lowest Yield Allocated  99.635 / 1.640Lowest Price / Highest Yield Allocated in Full  99.520 / 1.690Weighted Average of Successful Bids (Price/Yield)  99.575 / 1.660Best Bid (Price / Yield)  99.635 / 1.640Worst Bid (Price / Yield)  99.357 / 1.750Weighted Average of All Bids Received (Price / Yield)  99.524 / 1.680Percentage Partial Allocation (Approximate)  43.75 %Bid to Cover Ratio  2.22

Flokkur  RIKB 23 0515Greiðslu-og uppgjörsdagur  23.09.2020Samþykkt tilboð að nafnverði (m.kr.)  7.500Samþykkt (verð / ávöxtunarkrafa)  99,510 / 1,690Fjöldi innsendra tilboða  22Upphæð móttekinna tilboða að nafnverði (m.kr.)  16.650Fjöldi samþykktra tilboða  13Fjöldi samþykktra tilboða úthlutað að fullu  11Lægsta úthlutaða verð / Hæsta úthlutaða ávöxtunarkrafa  99,510 / 1,690Hæsta úthlutaða verð / Lægsta úthlutaða ávöxtunarkrafa  99,635 / 1,640Lægsta verð / Hæsta ávöxtunarkrafa úthlutað að fullu  99,520 / 1,690Vegið meðaltal samþykktra tilboða (verð / ávöxtunarkrafa)  99,575 / 1,660Besta tilboð (verð / ávöxtunarkrafa)  99,635 / 1,640Versta tilboð (verð / ávöxtunarkrafa)  99,357 / 1,750Vegið meðaltal innsendra tilboða (verð / ávöxtunarkrafa)  99,524 / 1,680Hlutfall samþykktra tilboða sem tekin...

GAINESVILLE, Ga., Sept. 18, 2020 (GLOBE NEWSWIRE) — Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for the development, formulation, regulatory support, manufacturing and packaging of oral solid dose drug products, today announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present at the Oppenheimer Fall Healthcare Life Sciences & Medtech Summit on Tuesday, September 22, 2020 at 4:10 p.m. ET.A live webcast of the presentation will be available on the “Presentations” page within the Investors section of the Recro website at https://ir.recropharma.com. A replay will be available on the Recro website for a period of 30 days following the event.About RecroRecro is a contract development and manufacturing, or CDMO, business,...

SAN DIEGO, Sept. 18, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it will be added to the Russell 2000®  Index, effective when the U.S. market opens on Friday, September 18, 2020.The Russell 2000® Index measures the performance of the small-cap segment of the U.S. equity market. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell’s U.S. indexes. Russell indexes are part of FTSE Russell, a leading global index provider.About ProgenityProgenity, Inc. is a biotechnology company with an established track record...

TORONTO, Sept. 18, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company“) announces pursuant to the requirements of National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and applicable Canadian securities legislation that on September 17, 2020, the Company completed a disposition of 6,000,000 common shares and $400,000 worth of convertible debentures of Inner Spirit Holdings Ltd. (“Inner Spirit”) for gross proceeds of $845,400, which reduces Auxly’s security holding percentage in Inner Spirit from 12.9% to 9.8%. The disposition was completed through the Canadian Securities Exchange where Inner Spirit’s common shares and convertible debentures are listed for trading. Since Auxly’s security holding percentage...

—Advancing VERU-111 to a Pivotal Phase 3 Clinical Program—MIAMI, Sept. 18, 2020 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer, today announced that positive clinical results from its Phase 1b study of VERU-111 were orally presented at the European Society for Medical Oncology (ESMO) Congress 2020.The results of the Phase 1b study evaluating VERU-111, a novel oral microtubule targeting agent that selectively inhibits alpha and beta tubulin, in 39 men with metastatic castration resistant prostate cancer that have also failed at least one androgen receptor targeting agent (enzalutamide or abiraterone) and a large and growing unmet medical need in advanced prostate cancer, have been presented as an oral presentation...

FLORIANÓPOLIS, Brazil, Sept. 18, 2020 (GLOBE NEWSWIRE) — Vitru Limited (“Vitru”), a Brazilian distance learning education group company, today announced the pricing of its initial public offering of 6,000,000 of its newly-issued common shares pursuant to a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (“SEC”) at a public offering price of $16.00 per share. The shares are expected to begin trading on the Nasdaq Global Select Market on September 18, 2020, under the symbol “VTRU” and the offering is expected to close on September 22, 2020, subject to customary closing conditions.In connection with the offering, Vitru has granted the underwriters a 30-day option to purchase up to an additional 900,000 common shares at the initial public offering price, less underwriting discounts and commissions.Goldman...

CAMBRIDGE, Mass., Sept. 18, 2020 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced the appointment of pharmaceutical industry leader Michael Kamarck, Ph.D., to its Board of Directors, effective immediately.“We are excited to welcome Dr. Kamarck to the board of directors,” said Robert L. Kirkman, M.D., Chair of Trillium Therapeutics.  “His long experience and expertise with the development and manufacturing of biologic products will be of particular value as Trillium is preparing to scale up its clinical development activities, with multiple phase 2 programs expected to start next year.”Dr. Kamarck has significant expertise in biologics manufacturing and a breadth of management...

PALM BAY, Fla., Sept. 18, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (Nasdaq:LGIH) today announced the introduction of brand-new, single-family homes in the city of Palm Bay, Florida.  Located off I-95 in southeast Orlando, LGI homeowners living in Palm Bay will have convenient access to nearby attractions for the entire family. The white-sand beaches of Melbourne Beach provide Palm Bay residents with gorgeous sunset views all year long. Business and leisure travelers can appreciate the quick access to the Orlando Melbourne International Airport, where direct flights for domestic and international travel are constantly expanding. In addition, retail therapy can be enjoyed nearby at the Vero Beach Outlets, where tremendous value is offered at over 40 designer and name brand retail stores.Palm Bay by LGI Homes is offering an array of...